4D Molecular Therapeutics, Inc. Shares Outstanding
4D Molecular Therapeutics, Inc. (FDMT) had Shares Outstanding of 55.21 million shares as of 2026-06-30, per its 10-Q filed 2026-08-13.
Prices
us-gaap:CommonStockSharesOutstanding · last filed 2026-08-13
- 2026-06-30: Shares outstanding (split-adjusted) 55.21M shares; Shares authorized (split-adjusted) 300.00M shares.
- 2026-03-31: Shares outstanding (split-adjusted) 52.27M shares; Shares authorized (split-adjusted) 300.00M shares.
- 2025-12-31: Shares outstanding (split-adjusted) 57.61M shares; Shares authorized (split-adjusted) 300.00M shares.
- 2025-09-30: Shares outstanding (split-adjusted) 46.77M shares; Shares authorized (split-adjusted) 300.00M shares.
| Period end | Shares outstanding (split-adjusted) | Shares authorized (split-adjusted) |
|---|---|---|
| 2026-06-30 | 55.21M shares 10-Q · filed 2026-08-13 | 300.00M shares 10-Q · filed 2026-08-13 |
| 2026-03-31 | 52.27M shares 10-Q · filed 2026-05-07 | 300.00M shares 10-Q · filed 2026-05-07 |
| 2025-12-31 | 57.61M shares 10-Q · filed 2026-08-13 | 300.00M shares 10-Q · filed 2026-08-13 |
| 2025-09-30 | 46.77M shares 10-Q · filed 2025-11-10 | 300.00M shares 10-Q · filed 2025-11-10 |
| 2025-06-30 | 46.70M shares 10-Q · filed 2025-08-11 | 300.00M shares 10-Q · filed 2025-08-11 |
| 2025-03-31 | 46.32M shares 10-Q · filed 2025-05-08 | 300.00M shares 10-Q · filed 2025-05-08 |
| 2024-12-31 | 45.79M shares 10-K · filed 2026-03-18 | 300.00M shares 10-K · filed 2026-03-18 |
| 2024-09-30 | 52.00M shares 10-Q · filed 2024-11-13 | 300.00M shares 10-Q · filed 2024-11-13 |
| 2024-06-30 | 51.91M shares 10-Q · filed 2024-08-08 | 300.00M shares 10-Q · filed 2024-08-08 |
| 2024-03-31 | 51.16M shares 10-Q · filed 2024-05-09 | 300.00M shares 10-Q · filed 2024-05-09 |
| 2023-12-31 | 43.08M shares 10-K · filed 2025-02-28 | 300.00M shares 10-K · filed 2025-02-28 |
| 2023-09-30 | 42.75M shares 10-Q · filed 2023-11-09 | 300.00M shares 10-Q · filed 2023-11-09 |
| 2023-06-30 | 42.02M shares 10-Q · filed 2023-08-09 | 300.00M shares 10-Q · filed 2023-08-09 |
| 2023-03-31 | 33.24M shares 10-Q · filed 2023-05-11 | 300.00M shares 10-Q · filed 2023-05-11 |
| 2022-12-31 | 32.63M shares 10-K · filed 2024-02-29 | 300.00M shares 10-K · filed 2024-02-29 |
| 2022-09-30 | 32.39M shares 10-Q · filed 2022-11-08 | 300.00M shares 10-Q · filed 2022-11-08 |
| 2022-06-30 | 32.38M shares 10-Q · filed 2022-08-11 | 300.00M shares 10-Q · filed 2022-08-11 |
| 2022-03-31 | 32.26M shares 10-Q · filed 2022-05-12 | 300.00M shares 10-Q · filed 2022-05-12 |
| 2021-12-31 | 32.22M shares 10-K · filed 2023-03-15 | 300.00M shares 10-K · filed 2023-03-15 |
| 2021-09-30 | 27.17M shares 10-Q · filed 2021-11-10 | 300.00M shares 10-Q · filed 2021-11-10 |
| 2021-06-30 | 26.89M shares 10-Q · filed 2021-08-12 | 300.00M shares 10-Q · filed 2021-08-12 |
| 2021-03-31 | 26.69M shares 10-Q · filed 2021-05-13 | 300.00M shares 10-Q · filed 2021-05-13 |
| 2020-12-31 | 26.68M shares 10-K · filed 2022-03-28 | 300.00M shares 10-K · filed 2022-03-28 |
| 2019-12-31 | 5.18M shares 10-K · filed 2021-03-25 | 50.00M shares 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| Aura Biosciences, Inc. (AURA) | United States | $0.639B | -5.61 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Entera Bio Ltd. (ENTX) | $0.485B |